OPNT

Opiant Pharmaceuticals News

Company Name Stock Ticker Symbol Market Type
Opiant Pharmaceuticals Inc OPNT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 20.12 17:29:30
Open Price Low Price High Price Close Price Prev Close
20.10 20.10 20.15 20.12 20.12
more quote information »

Recent News

Date Time Source Heading
11/22/202216:01GLOBEOpiant Pharmaceuticals Announces Completion of Rolling NDA..
11/15/202216:32EDGARCurrent Report Filing (8-k)
11/15/202206:10EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/15/202206:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/14/202216:25EDGARQuarterly Report (10-q)
11/14/202204:26TRMNHow Will Indivior’s $145M Purchase of Opiant Boost the..
11/14/202202:13GLOBEOpiant Pharmaceuticals Announces Third Quarter 2022..
11/14/202202:12GLOBEIndivior PLC to Acquire Opiant Pharmaceuticals
11/14/202202:10PRNUSIndivior To Acquire Opiant Pharmaceuticals
10/27/202216:05GLOBEOpiant Pharmaceuticals to Report Third Quarter 2022..
10/06/202208:01GLOBEOpiant Pharmaceuticals Announces Completion of Enrollment in..
8/22/202216:05GLOBEOpiant Pharmaceuticals Announces Notice of Allowance for..
8/12/202207:30PRNCAMindMed Strengthens Board with Appointment of Two New..
8/11/202216:11EDGARQuarterly Report (10-q)
8/11/202216:09EDGARCurrent Report Filing (8-k)
8/11/202216:05GLOBEOpiant Pharmaceuticals Announces Second Quarter and First..
8/08/202216:05GLOBEOpiant Pharmaceuticals Announces Additional $2.1 Million..
8/02/202216:05GLOBEOpiant Pharmaceuticals Announces Notice of Allowance for..
8/01/202216:05GLOBEOpiant Pharmaceuticals to Report Second Quarter 2022..
7/15/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202216:05EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202216:03EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202216:05GLOBEOpiant Reports Inducement Grants Under Nasdaq Listing Rule..
6/17/202216:54EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/17/202216:52EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/15/202216:32EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202217:01EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:56EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:54EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:49EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:17EDGARCurrent Report Filing (8-k)
6/13/202216:56EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202216:40EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202216:10EDGARCurrent Report Filing (8-k)
6/08/202216:05GLOBEOpiant Pharmaceuticals and Aptar Pharma Expand Long-Term..
6/06/202216:58EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202216:05GLOBEOpiant Pharmaceuticals Initiates Rolling Submission of New..
5/23/202216:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/20/202216:05GLOBEOpiant Pharmaceuticals to Hold Virtual 2022 Annual..
5/17/202216:05EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202216:13EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202216:10EDGARCurrent Report Filing (8-k)
5/10/202216:01GLOBEOpiant Pharmaceuticals Announces First Quarter 2022..
5/03/202208:00GLOBEOpiant Pharmaceuticals to Report First Quarter 2022..